Analyst Research: Merck & Co Inc (MRK.N)
MRK.N on New York Stock Exchange
47.74USD
3:48pm EDT
47.74USD
3:48pm EDT
Price Change (% chg)
$-0.01 (-0.02%)
$-0.01 (-0.02%)
Prev Close
$47.75
$47.75
Open
$47.75
$47.75
Day's High
$48.17
$48.17
Day's Low
$47.45
$47.45
Volume
1,792,259
1,792,259
Avg. Vol
3,969,615
3,969,615
52-wk High
$50.16
$50.16
52-wk Low
$38.88
$38.88
| Name | Age | Since | Current Position |
|---|---|---|---|
Kenneth Frazier |
58 | 2011 | Chairman of the Board, President, Chief Executive Officer |
Peter Kellogg |
56 | 2009 | Chief Financial Officer, Executive Vice President |
Clark Golestani |
46 | 2012 | Executive Vice President, Chief Information Officer |
Michael Holston |
50 | 2012 | Executive Vice President, Chief Ethics and Compliance Officer |
Bruce Kuhlik |
56 | 2009 | Executive Vice President, General Counsel |
- Exclusive: EU to fine Lundbeck, others for blocking generic drugs
- US STOCKS SNAPSHOT - Dow hits session highs, Merck rallies
- UPDATE 1-Merck melanoma drug shrinks tumors in 38 percent of patients
- Merck halts development of experimental Parkinson's drug
- UPDATE 2-Merck's insomnia drug moves a step closer to U.S. approval
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
